By Steve Lupo, Head of CGxP Digital Quality, Kymanox Corporation, Boston, Massachusetts, and Will Santana, Sr. Manager, CGxP Transformation, Brandon Sullivan, Sr. Director, Digital Transformation Services, and Brad Booth, Associate Director, Enterprise Quality, Kymanox Corporation, Morrisville, North Carolina
In 2022, digital technologies have come to the forefront of most industries and are involved in almost every aspect of business functions. At the same time, digitalization is rapidly evolving and often changing faster than companies can adjust. As a result, many companies fall behind the current digital and computational standards, which results in not only sub-optimal workflow, but also in gaps in digital security and data safety. The COVID-19 pandemic and the subsequent shift to virtual work further increased the need for user-friendly, secure, digital workspaces. However, transforming the digital infrastructure of a business is not always a straightforward task and can come with logistical challenges and workflow disruptions. Seamless adaptation of new digital technologies, or Digital Transformation towards Life Sciences 4.0, is possible if it is carefully planned out and tailored specifically to the needs of each business, whether a large biopharmaceutical company or a small life science company. This digital transformation will increase a company’s efficiency and improve its ability to better serve clients and patients. Here, we discuss some of the key points related to the adaptation of digital transformation 4.0.